Index - P/E - EPS (ttm) -0.39 Insider Own 49.01% Shs Outstand 96.24M Perf Week -4.83%
Market Cap 198.61M Forward P/E - EPS next Y -0.22 Insider Trans 0.89% Shs Float 74.17M Perf Month -21.47%
Income -43.82M PEG - EPS next Q -0.07 Inst Own 36.65% Short Float 0.56% Perf Quarter -32.63%
Sales 65.56M P/S 3.03 EPS this Y 45.63% Inst Trans 259.54% Short Ratio 1.14 Perf Half Y -11.72%
Book/sh 0.19 P/B 6.68 EPS next Y 37.76% ROA -46.24% Short Interest 0.42M Perf Year -14.09%
Cash/sh 0.20 P/C 6.30 EPS next 5Y - ROE -331.82% 52W Range 1.11 - 2.21 Perf YTD -30.43%
Dividend Est. - P/FCF - EPS past 5Y 8.42% ROI -49.15% 52W High -42.08% Beta 1.13
Dividend TTM - Quick Ratio 3.30 Sales past 5Y 24.79% Gross Margin 77.72% 52W Low 15.32% ATR (14) 0.10
Dividend Ex-Date - Current Ratio 3.40 EPS Y/Y TTM 56.19% Oper. Margin -52.71% RSI (14) 37.99 Volatility 9.43% 7.60%
Employees 217 Debt/Eq 2.22 Sales Y/Y TTM 48.91% Profit Margin -66.84% Recom 1.00 Target Price 3.10
Option/Short Yes / Yes LT Debt/Eq 2.20 EPS Q/Q 48.98% Payout - Rel Volume 1.94 Prev Close 1.20
Sales Surprise -2.24% EPS Surprise 4.24% Sales Q/Q 34.54% Earnings Nov 01 BMO Avg Volume 363.21K Price 1.28
SMA20 -7.90% SMA50 -18.30% SMA200 -17.48% Trades
Volume 702,982 Change 6.67%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-16-24 Initiated Scotiabank
Sector Outperform
Jul-26-24 Initiated Craig Hallum
Buy
$3
May-13-24 Initiated TD Cowen
Buy
$2.80
May-03-24 Initiated Lake Street
Buy
$3
Nov-17-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$21 → $11
Nov-23-20 Initiated William Blair
Outperform
Nov-23-20 Initiated Morgan Stanley
Overweight
$20
Nov-23-20 Initiated Canaccord Genuity
Buy
$26
Nov-23-20 Initiated BTIG Research
Buy
$22
Nov-20-24 09:35AM
Nov-02-24 03:01AM
Nov-01-24 07:15AM
06:00AM
Oct-31-24 09:06AM
06:00AM
Loading…
Oct-29-24 06:00AM
Oct-18-24 06:00AM
Oct-07-24 06:00AM
Sep-05-24 06:00AM
Aug-08-24 10:23AM
(Thomson Reuters StreetEvents)
Aug-07-24 06:05PM
04:01PM
Aug-06-24 06:00AM
Jul-24-24 06:00AM
Jun-18-24 08:13AM
06:00AM
Loading…
May-28-24 06:00AM
May-21-24 06:00AM
May-10-24 05:59PM
03:55PM
May-09-24 03:46AM
May-08-24 09:00PM
05:20PM
04:01PM
May-07-24 06:00AM
Apr-24-24 06:00AM
Apr-09-24 05:00PM
Apr-05-24 07:17AM
Mar-25-24 06:00AM
Mar-04-24 09:04AM
Mar-01-24 10:40PM
(Thomson Reuters StreetEvents)
06:31AM
Loading…
06:31AM
06:00AM
Feb-26-24 06:00AM
Feb-16-24 06:00AM
Feb-13-24 03:00AM
Jan-26-24 09:04AM
Nov-14-23 06:00AM
Nov-09-23 06:00AM
Nov-07-23 04:01PM
Oct-24-23 06:00AM
Oct-03-23 06:00AM
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-22-23 06:00AM
Aug-09-23 10:25AM
Aug-08-23 08:38AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
04:01PM
Aug-01-23 06:00AM
Jul-26-23 07:58AM
Jul-24-23 06:00AM
Jul-12-23 06:00AM
Jul-06-23 09:11AM
Jun-27-23 06:00AM
Jun-01-23 06:00AM
May-31-23 06:00AM
May-28-23 08:09AM
May-25-23 06:00AM
May-24-23 06:00AM
May-18-23 07:00AM
May-12-23 11:10AM
(Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM
04:01PM
May-09-23 06:15PM
Apr-27-23 06:00AM
Apr-12-23 06:53AM
Mar-15-23 09:31AM
(Simply Wall St.) +15.24%
Mar-08-23 07:14AM
Mar-06-23 07:25AM
06:00AM
Feb-28-23 06:00AM
Feb-21-23 06:00AM
Feb-16-23 06:27AM
Dec-19-22 06:00AM
Dec-16-22 04:01PM
Dec-12-22 06:00AM
Nov-21-22 04:01PM
(Business Wire) -7.14%
+13.85%
Nov-17-22 12:26AM
Nov-16-22 04:05PM
04:01PM
Nov-10-22 09:00AM
Nov-09-22 05:33AM
Nov-03-22 07:15AM
06:00AM
Oct-20-22 06:00AM
Oct-17-22 05:05PM
(American City Business Journals)
06:00AM
Oct-12-22 06:00AM
Oct-11-22 06:00AM
Sep-06-22 06:00AM
Aug-09-22 06:00AM
Aug-06-22 04:30AM
Aug-04-22 07:15AM
06:00AM
Aug-03-22 06:00AM
Jul-30-22 10:44AM
Jul-20-22 06:00AM
Jul-19-22 06:00AM
Jun-22-22 09:19AM
Jun-15-22 10:11AM
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SCHULER JACK W Director Nov 21 '24 Buy 1.23 100,000 122,840 31,194,935 Nov 22 12:30 PM Kennedy Lawrence T. Jr Director Nov 21 '24 Buy 1.16 35,000 40,562 10,411,024 Nov 22 12:30 PM SCHULER JACK W Director Nov 20 '24 Buy 1.17 200,000 234,000 31,094,935 Nov 21 03:30 PM Vazquez Chris Chief Accounting Officer Nov 11 '24 Sale 1.39 105 146 11,685 Nov 13 04:22 PM Vazquez Chris Chief Accounting Officer Nov 12 '24 Sale 1.40 98 137 11,587 Nov 13 04:22 PM Pestano Gary Anthony Chief Development Officer Nov 11 '24 Sale 1.39 220 306 127,234 Nov 13 04:22 PM Pestano Gary Anthony Chief Development Officer Nov 12 '24 Sale 1.40 207 290 127,027 Nov 13 04:22 PM O'Kane Kieran Chief Commercial Officer Nov 11 '24 Sale 1.39 238 331 97,672 Nov 13 04:21 PM O'Kane Kieran Chief Commercial Officer Nov 12 '24 Sale 1.40 224 314 97,448 Nov 13 04:21 PM Hutton Scott President & CEO Nov 11 '24 Sale 1.39 1,927 2,680 534,792 Nov 13 04:21 PM Hutton Scott President & CEO Nov 12 '24 Sale 1.40 1,813 2,540 532,979 Nov 13 04:21 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 11 '24 Sale 1.39 500 695 203,807 Nov 13 04:21 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 12 '24 Sale 1.40 471 660 203,336 Nov 13 04:21 PM Strobeck Matthew Director Nov 05 '24 Buy 1.40 40,000 55,916 2,606,879 Nov 06 03:16 PM SCHULER JACK W Director Nov 05 '24 Buy 1.36 100,253 136,585 30,894,935 Nov 06 03:16 PM PATIENCE JOHN Chairman Nov 05 '24 Buy 1.38 75,000 103,710 2,153,298 Nov 06 03:16 PM MASSARANY HANY Director Nov 05 '24 Buy 1.37 22,500 30,865 53,364 Nov 06 03:15 PM Kennedy Lawrence T. Jr Director Nov 05 '24 Buy 1.36 51,200 69,888 10,356,024 Nov 06 03:15 PM Kennedy Lawrence T. Jr Director Nov 06 '24 Buy 1.36 20,000 27,180 10,376,024 Nov 06 03:15 PM Vazquez Chris Chief Accounting Officer Aug 09 '24 Sale 1.60 155 248 11,242 Aug 12 07:24 PM Vazquez Chris Chief Accounting Officer Aug 12 '24 Sale 1.57 54 85 11,188 Aug 12 07:24 PM Pestano Gary Anthony Chief Development Officer Aug 09 '24 Sale 1.60 320 512 126,187 Aug 12 07:24 PM Pestano Gary Anthony Chief Development Officer Aug 12 '24 Sale 1.57 111 174 126,076 Aug 12 07:24 PM O'Kane Kieran Chief Commercial Officer Aug 09 '24 Sale 1.60 345 552 89,748 Aug 12 07:24 PM O'Kane Kieran Chief Commercial Officer Aug 12 '24 Sale 1.57 120 189 89,628 Aug 12 07:24 PM Hutton Scott President & CEO Aug 09 '24 Sale 1.60 2,781 4,452 519,331 Aug 12 07:23 PM Hutton Scott President & CEO Aug 12 '24 Sale 1.57 963 1,514 518,368 Aug 12 07:23 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 09 '24 Sale 1.60 724 1,159 191,402 Aug 12 07:23 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 12 '24 Sale 1.57 251 395 191,151 Aug 12 07:23 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 21 '24 Option Exercise 0.42 4,209 1,768 175,889 May 23 07:13 PM Vazquez Chris Chief Accounting Officer May 09 '24 Sale 1.48 244 361 9,915 May 10 05:06 PM Pestano Gary Anthony Chief Development Officer May 09 '24 Sale 1.48 434 642 124,248 May 10 05:06 PM O'Kane Kieran Chief Commercial Officer May 09 '24 Sale 1.48 468 692 75,524 May 10 05:05 PM Hutton Scott President & CEO May 09 '24 Sale 1.48 3,764 5,569 483,780 May 10 05:04 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 09 '24 Sale 1.48 980 1,450 171,680 May 10 05:04 PM Vazquez Chris Chief Accounting Officer Feb 09 '24 Sale 1.92 1,077 2,064 10,470 Feb 12 09:46 PM Vazquez Chris Chief Accounting Officer Feb 12 '24 Sale 1.66 922 1,535 9,548 Feb 12 09:46 PM Pestano Gary Anthony Chief Development Officer Feb 09 '24 Sale 1.92 5,862 11,235 128,272 Feb 12 09:45 PM Pestano Gary Anthony Chief Development Officer Feb 12 '24 Sale 1.66 5,022 8,360 123,250 Feb 12 09:45 PM O'Kane Kieran Chief Commercial Officer Feb 09 '24 Sale 1.92 6,319 12,111 73,417 Feb 12 09:45 PM O'Kane Kieran Chief Commercial Officer Feb 12 '24 Sale 1.66 5,412 9,009 68,005 Feb 12 09:45 PM Hutton Scott President & CEO Feb 09 '24 Sale 1.92 34,682 66,472 494,719 Feb 12 09:45 PM Hutton Scott President & CEO Feb 12 '24 Sale 1.66 29,708 49,455 465,011 Feb 12 09:45 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 09 '24 Sale 1.92 10,156 19,465 178,109 Feb 12 09:44 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 12 '24 Sale 1.66 8,699 14,481 169,410 Feb 12 09:44 PM
Index - P/E - EPS (ttm) -2.72 Insider Own 41.45% Shs Outstand 25.04M Perf Week -11.35%
Market Cap 40.33M Forward P/E - EPS next Y -2.00 Insider Trans 0.00% Shs Float 14.66M Perf Month -7.34%
Income -53.45M PEG - EPS next Q -0.50 Inst Own 19.26% Short Float 3.48% Perf Quarter -9.89%
Sales 11.91M P/S 3.39 EPS this Y 49.01% Inst Trans -34.17% Short Ratio 8.29 Perf Half Y 18.84%
Book/sh -1.95 P/B - EPS next Y 13.05% ROA -149.23% Short Interest 0.51M Perf Year -64.66%
Cash/sh 0.85 P/C 1.93 EPS next 5Y 30.00% ROE - 52W Range 0.73 - 5.23 Perf YTD -58.16%
Dividend Est. - P/FCF - EPS past 5Y 21.16% ROI -558.51% 52W High -68.64% Beta 0.58
Dividend TTM - Quick Ratio 1.34 Sales past 5Y 18.48% Gross Margin 24.25% 52W Low 124.66% ATR (14) 0.12
Dividend Ex-Date - Current Ratio 1.50 EPS Y/Y TTM 55.49% Oper. Margin -320.01% RSI (14) 36.65 Volatility 7.18% 6.11%
Employees 134 Debt/Eq - Sales Y/Y TTM -0.79% Profit Margin -448.86% Recom 2.00 Target Price 1.00
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q -1040.16% Payout - Rel Volume 0.60 Prev Close 1.67
Sales Surprise -1.65% EPS Surprise -15.34% Sales Q/Q -9.82% Earnings Nov 07 AMC Avg Volume 61.59K Price 1.64
SMA20 -11.77% SMA50 -8.34% SMA200 22.23% Trades
Volume 37,260 Change -1.80%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-09-22 Downgrade Craig Hallum
Buy → Hold
$5
Oct-08-20 Initiated BTIG Research
Neutral
Aug-07-20 Upgrade Craig Hallum
Hold → Buy
$20
Sep-27-19 Downgrade JP Morgan
Neutral → Underweight
$16
Nov-07-18 Downgrade JP Morgan
Overweight → Neutral
May-24-18 Initiated Craig Hallum
Hold
$25
Dec-13-17 Downgrade BTIG Research
Buy → Neutral
Jul-12-17 Resumed BTIG Research
Buy
$34
Mar-24-16 Initiated JP Morgan
Overweight
$17
Dec-16-15 Initiated Piper Jaffray
Overweight
Nov-08-24 09:15AM
(Thomson Reuters StreetEvents) -7.11%
02:28AM
Nov-07-24 05:40PM
04:32PM
(Associated Press Finance)
04:05PM
04:30PM
Loading…
Oct-25-24 04:30PM
Oct-09-24 05:56PM
Oct-01-24 06:33AM
(Medical Device Network) +8.19%
Sep-30-24 09:15AM
Aug-14-24 10:05AM
Aug-08-24 05:45PM
04:41PM
(Associated Press Finance)
04:05PM
04:00PM
11:09AM
12:28PM
Loading…
May-09-24 12:28PM
06:04AM
(Thomson Reuters StreetEvents)
03:43AM
May-08-24 09:57PM
06:25PM
05:22PM
(Associated Press Finance)
04:42PM
May-02-24 10:01AM
09:30AM
Apr-02-24 10:51AM
Mar-29-24 05:57AM
(Thomson Reuters StreetEvents)
Mar-28-24 09:53PM
05:45PM
04:05PM
Mar-07-24 09:30AM
09:20AM
Loading…
Jan-19-24 09:20AM
Jan-16-24 07:45AM
Jan-07-24 08:00PM
Nov-29-23 08:43AM
Nov-27-23 09:15AM
Nov-22-23 09:35AM
Nov-11-23 10:44AM
Nov-09-23 06:42PM
(Associated Press Finance)
04:05PM
Oct-30-23 09:30AM
Oct-03-23 08:50AM
Sep-14-23 11:01PM
Aug-11-23 05:59AM
(Thomson Reuters StreetEvents)
Aug-10-23 05:30PM
04:26PM
(Associated Press Finance)
04:05PM
Jul-27-23 09:30AM
Jul-10-23 09:00AM
Jun-29-23 09:40AM
Jun-13-23 09:40AM
09:00AM
07:03AM
May-23-23 09:40AM
May-12-23 09:53AM
(Thomson Reuters StreetEvents)
May-11-23 05:25PM
04:20PM
04:05PM
09:09AM
May-10-23 11:18AM
10:23AM
09:23AM
Apr-27-23 09:30AM
Apr-19-23 08:38AM
Apr-17-23 06:38AM
(Simply Wall St.) +13.64%
Apr-03-23 12:00PM
Apr-01-23 12:47PM
Mar-29-23 05:25PM
04:05PM
Mar-15-23 09:30AM
Mar-14-23 08:00PM
Mar-08-23 08:30AM
Feb-06-23 05:23AM
Dec-19-22 01:32PM
Nov-16-22 10:22AM
Nov-14-22 04:05PM
(PR Newswire) +5.63%
-18.67%
Oct-24-22 01:52PM
10:02AM
Oct-19-22 01:27PM
Aug-23-22 08:02AM
(Simply Wall St.) +12.59%
Aug-19-22 04:50PM
(American City Business Journals) -49.40%
+13.49%
Aug-18-22 09:30PM
09:28AM
Aug-17-22 06:00PM
Aug-15-22 02:41PM
08:15AM
06:50AM
Jul-28-22 07:09AM
Jul-25-22 09:30AM
Jul-11-22 08:00AM
Jun-13-22 06:55AM
May-23-22 09:30AM
May-16-22 06:15PM
04:05PM
08:06AM
May-12-22 06:25PM
May-10-22 05:55PM
May-05-22 09:00AM
May-04-22 08:25AM
Apr-29-22 09:30AM
Apr-25-22 08:41AM
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MASSARANY HANY Director Jun 28 '24 Option Exercise 0.00 4,737 0 36,891 Jul 01 06:32 PM FRANCESCONI LOUISE Director Jun 28 '24 Option Exercise 0.00 4,737 0 33,558 Jul 01 06:31 PM SCHULER JACK W Director Jun 28 '24 Option Exercise 0.00 4,737 0 20,225 Jul 01 06:30 PM BURRIS WAYNE Director May 31 '24 Option Exercise 0.00 839 0 1,678 Jun 03 05:06 PM FRANCESCONI LOUISE Director May 29 '24 Option Exercise 0.00 7,894 0 28,821 May 30 04:25 PM Regan Jennifer Director May 29 '24 Option Exercise 0.00 12,631 0 12,631 May 30 04:25 PM SCHULER JACK W Director May 29 '24 Option Exercise 0.00 7,894 0 15,488 May 30 04:25 PM MASSARANY HANY Director May 29 '24 Option Exercise 0.00 7,894 0 32,154 May 30 04:16 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Option Exercise 0.00 1,283 0 82,114 May 21 07:03 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Sale 0.88 361 318 81,831 May 21 07:03 PM Phillips Jack Chief Executive Officer Apr 17 '24 Option Exercise 0.00 59,928 0 189,654 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 17 '24 Sale 0.78 26,735 20,853 162,919 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Option Exercise 0.00 59,928 0 156,271 Apr 16 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Sale 0.86 26,545 22,829 129,726 Apr 16 04:10 PM Patience David Chief Financial Officer Apr 09 '24 Option Exercise 0.00 37,468 0 63,715 Apr 10 05:27 PM Patience David Chief Financial Officer Apr 09 '24 Sale 0.87 13,296 11,568 50,419 Apr 10 05:27 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Option Exercise 0.00 40,633 0 95,090 Apr 10 05:26 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Sale 0.87 13,984 12,166 81,106 Apr 10 05:26 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Option Exercise 0.00 2,866 0 55,435 Apr 05 04:29 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Sale 0.88 978 861 54,457 Apr 05 04:29 PM Phillips Jack Chief Executive Officer Apr 04 '24 Option Exercise 0.00 35,523 0 112,230 Apr 05 04:26 PM Phillips Jack Chief Executive Officer Apr 04 '24 Sale 0.88 15,887 13,981 96,343 Apr 05 04:26 PM Patience David Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,000 0 26,597 Feb 27 06:59 PM Patience David Chief Financial Officer Feb 26 '24 Sale 0.96 350 336 26,247 Feb 27 06:59 PM Phillips Jack Chief Executive Officer Feb 01 '24 Option Exercise 0.00 1,000 0 77,201 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Feb 01 '24 Sale 1.30 494 642 76,707 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Dec 13 '23 Option Exercise 0.00 1,721 0 60,274 Dec 14 05:15 PM Phillips Jack Chief Executive Officer Dec 13 '23 Sale 4.39 739 3,244 59,535 Dec 14 05:15 PM Patience David Chief Financial Officer Dec 13 '23 Option Exercise 0.00 331 0 9,028 Dec 14 05:14 PM Patience David Chief Financial Officer Dec 13 '23 Sale 4.39 97 426 8,931 Dec 14 05:14 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
